AGE-RELATED MACULAR DEGENERATION
Clinical trials for AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cell transplant shows promise for blinding eye disease
Disease control OngoingThis study tests a new treatment called OpRegen for people with advanced dry age-related macular degeneration (geographic atrophy), a leading cause of vision loss. The treatment uses special cells grown from stem cells that are placed under the retina to replace damaged cells. Th…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 29, 2026 03:59 UTC
-
One shot to save sight? gene therapy trial aims to end monthly eye injections
Disease control OngoingThis early-stage trial tests a gene therapy called KH631 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment delivers a protein that blocks abnormal blood vessel growth, potentially replacing the need for regular eye injection…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: Chengdu Origen Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 03:58 UTC
-
Scientists track eye health over five years in AREDS participants
Knowledge-focused OngoingThis study follows 110 adults aged 50 and older who previously took part in the AREDS or AREDS2 studies. Researchers will conduct annual eye exams, including vision tests and eye photographs, to monitor the natural progression of age-related macular degeneration and cataracts. Th…
Matched conditions: AGE-RELATED MACULAR DEGENERATION
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Apr 29, 2026 03:57 UTC